Abstract
Study objectives: Treatment of chronic obstructive pulmonary disease (COPD) in the emergency department (ED) or hospital accounts for a significant portion of COPD costs. This study estimates the cost of a COPD ED or hospitalization visit in the US.
Design: This observational study utilized administrative data from 218 acute care hospitals. ED/hospital discharges for COPD (International Classification of Diseases — Ninth Revision — Clinical Modification codes 491.xx. 492.xx, 496.xx) during 2001 were identified. Costs were determined for three groups: (i) ED only; (ii) standard admission; and (iii) severe admissions (intensive care unit [ICU] or intubation). Severe admissions were stratified into: (i) ICU/no intubation; (ii) intubation/no ICU; and (iii) ICU + intubation. Mean total costs and length of stay (LOS) were calculated for each group.
Results: A total of 59 735 ED/hospital encounters were identified: 20 431 ED only, 33 210 standard admissions, and 6094 severe admissions (4456 ICU/no intubation, 496 intubation/no ICU, and 1142 ICU/intubation). ED visits had a mean cost of $US571 ± 507 (year 2001 value). Inpatient costs ranged from $US5997 (± 5752) for a standard admission to $US36 743 (± 62 886) for ICU plus intubation admissions, while LOS ranged from 5.1 days (±4.5) to 14.8 days (± 16.7), respectively. In addition, only 10% of encounters required an intubation/ICU admission, but these accounted for 34% of the cost.
Conclusion: Cost of a COPD hospitalization is substantial in the US, with one-third of those costs being associated with severe admissions, which make up only 10% of all COPD admissions. Treatments aimed at reducing hospitalizations and length of stay could result in substantial cost savings.
Similar content being viewed by others
References
Murphy SL. Deaths: final data for 1998. Natl Vital S tat Rep 2000; 48: 1–105
National Institutes of Health. 2004 Chart Book. Bethesda (MD): National Heart, Lung and Blood institute (NHLBI), 2004
American Lung Association. Trends in chronic bronchitis and emphysema: morbidity and mortality 2003 [online]. Available from URL: http://www.lungusa.org/data/copd/copdl.pdf [Accessed 2003 Mar 1]
Strassels SA, Smith DH, Sullivan SD, et al. The costs of treating COPD in the United States. Chest 2001; 119: 344–52
Seemungal TA, Donaldson GC, Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 1608–13
Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418–22
Connors Jr AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996; 154: 959–67
Mushlin AI, Black ER, Connolly CA, et al. The necessary length of hospital stay for chronic pulmonary disease. JAMA 1991; 266: 80–3
Afessa B, Morales IJ, Scanlon PD, et al. Prognostic factors, clinical course, and hospital outcome of patients with chronic obstructive pulmonary disease admitted to an intensive care unit for acute respiratory failure. Crit Care Med 2002; 30: 1610–5
Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–83
Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993; 46: 1075–9
Center for Medicare and Medicaid Services. Prospective payment system payment impact file (May 2001 Update) [online]. Available from URL: http://cms.hhs.gov/providers/pufdownload/defaultasp [Accessed 2002 Jul 25]
Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc 1983; 78: 605–10
SAS Institute. SAS Procedures Guide, Version 8. 2. Cary (NC): SAS Institute, 2002
Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance: United States, 1971–2000. Respir Care 2002; 47: 1184–99
Garcia-Aymerich J, Farrero E, Felez MA, et al. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58:100–5
Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project Page [online]. Available from URL: http://www.ahrq.gov/data/hcup/hcupnet.htm [Accessed 2003 Mar 1]
Acknowledgments
This research was funded by GlaxoSmithKline. RH Stanford is an employee at GlaxoSmithKline.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stanford, R.H., Shen, Y. & McLaughlin, T. Cost of Chronic Obstructive Pulmonary Disease in the Emergency Department and Hospital. Treat Respir Med 5, 343–349 (2006). https://doi.org/10.2165/00151829-200605050-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151829-200605050-00005